West Virginia HB4771 amends the Controlled Substances Monitoring Program to enhance oversight and reporting of controlled substance prescribing and.

West Virginia HB4771 amends the Controlled Substances Monitoring Program to establish an advisory committee and a review committee. The advisory committee will develop parameters to identify abnormal or unusual usage patterns of controlled substances for patients and practitioners. The review committee will query the database to identify unusual prescribing or dispensing patterns and notify relevant authorities. The Board of Pharmacy will issue reports on these patterns and provide recommendations for reducing inappropriate use of prescription drugs.

West Virginia HB4771 amends the Controlled Substances Monitoring Program to enhance oversight and reporting of controlled substance prescribing and.

West Virginia HB4771 amends the Controlled Substances Monitoring Program to establish an advisory committee and a review committee. The advisory committee will develop parameters to identify abnormal or unusual usage patterns of controlled substances for patients and practitioners. The review committee will query the database to identify unusual prescribing or dispensing patterns and notify relevant authorities. The Board of Pharmacy will issue reports on these patterns and provide recommendations for reducing inappropriate use of prescription drugs.